| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 231,663 | 313,968 | 271,155 | 260,981 | | Cost of Revenue | 142,875 | 224,153 | 192,026 | 180,945 | | | Gross Profit | 88,788 | 89,815 | 79,129 | 80,036 | | | Operating Expenses | | Research Development | 1,360 | 1,299 | 1,257 | 1,180 | | Selling General and Administrative | 34,895 | 39,801 | 38,433 | 34,783 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 19,575 | 27,904 | 25,326 | 25,302 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 32,958 | 20,811 | 14,113 | 18,771 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,335) | 143 | (45) | (1,331) | | Earnings Before Interest And Taxes | 31,623 | 20,954 | 14,068 | 14,131 | | Interest Expense | 9,324 | 8,647 | 6,539 | 5,490 | | Income Before Tax | 22,299 | 12,307 | 7,529 | 8,641 | | Income Tax Expense | 8,943 | 5,349 | 1,939 | 4,421 | | Minority Interest | (3,627) |
-
|
-
| (3,647) | | | | Net Income From Continuing Ops | 13,356 | 6,958 | 5,590 | 4,220 | | | Non-recurring Events | | Discontinued Operations | 28,007 |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 37,736 | 6,958 | 5,590 | 4,220 | | Preferred Stock And Other Adjustments | 3,627 |
-
| (3,627) |
-
| | | Net Income Applicable To Common Shares | $41,363 | $6,958 | $1,963 | $4,220 |
|
0.51% Nasdaq 
Income Statement
